Podcast - Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 2
Podcast
0.5 AMA PRA Category 1 Credit™ ...Faculty
OVERVIEW
Podcast - Schizophrenia Update: Navigating the Latest in Research and Treatment - Module 2 is organized by i3 Health.
Dates Available:
February 18, 2025 - February 17, 2026
Statement of Need:
Schizophrenia, a debilitating mental illness characterized by psychotic symptoms such as hallucinations and delusions, affects more than 24 million people throughout the world (National Institute of Mental Health, 2024; Wang et al, 2024). The primary form of treatment for schizophrenia is oral antipsychotic drugs, but these treatments are often associated with suboptimal adherence due to side effects and dosing schedules. Long-acting injectables (LAIs) are a novel formulation of antipsychotics with advantages such as less frequent dosing and the potential for improved adherence due to slower absorption and steadier blood concentrations, which may result in less toxicity and better tolerance (Wang et al, 2024). In recent years, more LAI formulations have become available with extended indications, expanded dose intervals, and improved initiation strategies, but these are still underutilized (Wang et al, 2024; Højlund & Correll, 2023). It is crucial for members of the interdisciplinary care team to stay up to date on LAIs in order to improve outcomes for patients. In Module 2 of this podcast, Dr. Christoph U. Correll, Professor of Psychiatry and Molecular Medicine at Donald and Barbara Zucker School of Medicine at Hofstra/Northwell Health, and Professor and Chair of the Department of Child and Adolescent Psychiatry at Charité – University Medicine in Berlin, Germany, will provide insights into improving treatment adherence through the use of LAIs for schizophrenia.
Learning Objective:
Upon completion of this activity, participants should be able to
- Assess the indications, efficacy, and safety of novel and emerging LAI formulations of antipsychotics for the treatment of schizophrenia
ACCREDITATION & CREDITS
Jointly Accredited Provider
In support of improving patient care, i3 Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
i3 Health designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
By providing this information, participants are agreeing to allow i3 Health to share this information with the ACCME.
Physician Assistants/Associates
i3 Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid until 2/17/26. PAs should only claim credit commensurate with the extent of their participation.
Nurse Practitioners
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.
Nursing Continuing Professional Development
A maximum of 0.5 ANCC contact hours may be earned by learners who successfully complete this nursing continuing professional development activity. This activity has been designated for 0.5 ANCC contact hours of pharmacology credit for Advanced Practice Registered Nurses.
Provider approved by the California Board of Registered Nursing, for 0.5 ANCC contact hours.
Continuing Pharmacy Education
i3 Health has approved this knowledge-based activity for 0.5 ACPE CE hours. Pharmacy CE credits can be submitted to the NABP upon successful completion of the activity and the evaluation by providing your NABP ID and DOB, which must be submitted within 60 days of completion.
TARGET AUDIENCE
PhysicianNursingPharmacistPhysician AssistantHealthcare ProfessionalsPsychiatristsMental Health NursesNurse PractitionersSPECIALITIES
Psychiatry
Quick Links